## BACKGROUND. The objective of the current study was to analyze the impact of adjuvant chemotherapy in comparison with other prognostic parameters on the outcome of a series of patients with breast carcinoma at time of metastatic recurrence. ## METHODS. Data from 1430 patients accrued in 8 pro
The prognostic significance of sialyl-tn Antigen in women treated with breast carcinoma treated with adjuvant chemotherapy
β Scribed by Anita Yeomans Kinney; Aysegul Sahin; Sally W. Vernon; Ralph F. Frankowski; John F. Annegers; Gabriel N. Hortobagyi; Aman U. Buzdar; Debra K. Frye; Kapil Dhingra
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 116 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Results
. Forty-eight (23%) of the 207 specimens demonstrated high STn staining ter, Houston, Texas.
(ΓΊ25% cells were immunoreactive). During a median follow-up of 5 years, high STn patients had worse disease free survival than low STn patients (55% vs. 74%,
π SIMILAR VOLUMES
## Background: A phase ii study was performed evaluating the disease free and overall survival rates associated with a dose-intensive, 16-week, doxorubicin-based adjuvant chemotherapy regimen in women with breast carcinoma and > or = 10 involved axillary lymph nodes. ## Methods: Eligible patients
## BACKGROUND. Although in recent years there has been a dramatic increase in both the incidence of ductal carcinoma in situ (DCIS) and breast-conserving therapy for patients who have this disease, the optimal treatment for these patients remains controversial. Most data regarding outcomes have co